Cargando…
Allogeneic bone marrow transplantation for juvenile myelomonocytic leukemia: a single center experience of 23 patients
Juvenile myelomonocytic leukemia (JMML) is a childhood leukemia for which allogeneic BMT is the only curative therapy. At our pediatric stem cell transplantation unit, we performed 26 BMTs in 23 children (age 0.5–12.7 years). Conditioning was CY/TBI based (1980–1996, n=14) or BU/CY/melphalan based (...
Autores principales: | Korthof, E T, Snijder, P P, de Graaff, A A, Lankester, A C, Bredius, R G M, Ball, L M, Lie, J L W T, Vossen, J M, Egeler, R M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091614/ https://www.ncbi.nlm.nih.gov/pubmed/15654356 http://dx.doi.org/10.1038/sj.bmt.1704778 |
Ejemplares similares
-
Complete Suppression of the Gut Microbiome Prevents Acute Graft-Versus-Host Disease following Allogeneic Bone Marrow Transplantation
por: Vossen, Jaak M., et al.
Publicado: (2014) -
The Genomic Landscape of Juvenile Myelomonocytic Leukemia
por: Stieglitz, Elliot, et al.
Publicado: (2015) -
Current Treatment of Juvenile Myelomonocytic Leukemia
por: Mayerhofer, Christina, et al.
Publicado: (2021) -
Cytosine Arabinoside and Mitoxantrone Followed by Second Allogeneic Transplant for the Treatment of Children With Refractory Juvenile Myelomonocytic Leukemia
por: Patel, Sachit A., et al.
Publicado: (2014) -
Novel splicing-factor mutations in juvenile myelomonocytic leukemia
por: Takita, J, et al.
Publicado: (2012)